A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem. NgTat Ming KhongWendy X. HarrisPatrick N. A. DePartha P. ChowAngela A. TambyahPaul C. LyeDavid 2016 <p>A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.</p>